BCM

Boone Capital Management Portfolio holdings

AUM $233M
This Quarter Return
+3.42%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$317M
AUM Growth
+$317M
Cap. Flow
+$36.8M
Cap. Flow %
11.62%
Top 10 Hldgs %
88.65%
Holding
16
New
3
Increased
9
Reduced
1
Closed
3

Top Buys

1
GMED icon
Globus Medical
GMED
$21.3M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
$12.3M
3
BIIB icon
Biogen
BIIB
$8.54M
4
BBIO icon
BridgeBio Pharma
BBIO
$8.26M
5
CI icon
Cigna
CI
$5.54M

Top Sells

1
ABBV icon
AbbVie
ABBV
$11.9M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$9.54M
3
TBRG icon
TruBridge
TBRG
$8.62M
4
BAX icon
Baxter International
BAX
$8.24M

Sector Composition

1 Healthcare 86.54%
2 Financials 13.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UNM icon
1
Unum
UNM
$11.9B
$42.7M 13.46% 867,565 +10,000 +1% +$492K
CI icon
2
Cigna
CI
$80.3B
$37.2M 11.73% 129,917 +19,366 +18% +$5.54M
MOH icon
3
Molina Healthcare
MOH
$9.8B
$37.1M 11.71% 113,178 +6,659 +6% +$2.18M
DHR icon
4
Danaher
DHR
$147B
$32M 10.11% 129,163 +19,253 +18% +$4.78M
ENOV icon
5
Enovis
ENOV
$1.77B
$26.5M 8.36% 502,731 +74,938 +18% +$3.95M
AMGN icon
6
Amgen
AMGN
$155B
$26.4M 8.32% 98,126 +14,627 +18% +$3.93M
BIIB icon
7
Biogen
BIIB
$19.4B
$24.7M 7.79% 96,115 +33,238 +53% +$8.54M
GMED icon
8
Globus Medical
GMED
$8.27B
$21.3M 6.71% +428,452 New +$21.3M
BAX icon
9
Baxter International
BAX
$12.7B
$17.7M 5.59% 469,405 -218,296 -32% -$8.24M
QTRX icon
10
Quanterix
QTRX
$211M
$15.4M 4.87% 568,544 +67,400 +13% +$1.83M
IDYA icon
11
IDEAYA Biosciences
IDYA
$2.15B
$15.4M 4.86% 570,682 +74,249 +15% +$2M
MIRM icon
12
Mirum Pharmaceuticals
MIRM
$3.71B
$12.3M 3.89% +389,791 New +$12.3M
BBIO icon
13
BridgeBio Pharma
BBIO
$9.89B
$8.26M 2.61% +313,381 New +$8.26M
ABBV icon
14
AbbVie
ABBV
$372B
– – -88,026 Closed -$11.9M
TBRG icon
15
TruBridge
TBRG
$300M
– – -349,245 Closed -$8.62M
CERE
16
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– – -300,000 Closed -$9.54M